• Fennec Pharmaceuticals granted 10,000 incentive stock options to a new non-executive employee under its 2026 Equity Inducement Plan.
• Options carry a $9 per share exercise price, matching the June 12 Nasdaq close; term runs 10 years from the June 15 grant date.
• One-third vests on the first anniversary; remaining options vest monthly over the next 24 months, subject to continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fennec Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606150600PRIMZONEFULLFEED9746793) on June 15, 2026, and is solely responsible for the information contained therein.